- Page 1 and 2: The Toxicologist Supplement to Toxi
- Page 3 and 4: The Toxicologist Supplement to Toxi
- Page 5 and 6: 1 A Refresher of Immunoglobulin and
- Page 7 and 8: 12 Understanding Toxic Neuropathy i
- Page 9 and 10: SWCNTs (raw FeSWCNT or purified cSW
- Page 11 and 12: 34 Computational Systems Biology Mo
- Page 13 and 14: driving allergic airway response, c
- Page 15 and 16: E100, E0 vapors caused no overt mat
- Page 17 and 18: in heart rate, blood pressure, brea
- Page 19 and 20: hearts showed a coronary artery dis
- Page 21 and 22: inducible NADPH oxidase dependent m
- Page 23: 93 Simulated Metabolism in the Lang
- Page 27 and 28: 112 Endocrine Disruption Potential
- Page 29 and 30: The incorporation of in vitro data
- Page 31 and 32: was validated by the following resu
- Page 33 and 34: 139 A Systematic Analysis of ToxCas
- Page 35 and 36: 148 Mucosa-Associated Enteropathoge
- Page 37 and 38: 158 The Cannabinoid WIN 55, 212-2 D
- Page 39 and 40: signaling. ARNT is expressed as two
- Page 41 and 42: 177 Modifying Effect of Glycidol Fa
- Page 43 and 44: 24 and 72 hours post treatment. We
- Page 45 and 46: line and the effects of the haploty
- Page 47 and 48: organ weight, gross findings, or hi
- Page 49 and 50: 215 Acute and Delayed Effects of In
- Page 51 and 52: 224 Interaction of Human Bronchial
- Page 53 and 54: espiratory and olfactory mucosal le
- Page 55 and 56: hyperresponsiveness to MCh aerosol
- Page 57 and 58: shown that the collagen content is
- Page 59 and 60: fect is consistently higher in male
- Page 61 and 62: surrogate) in the presence or absen
- Page 63 and 64: of field controls were 46.3 ± 5 μ
- Page 65 and 66: 290 Interpretation of Multiroute Da
- Page 67 and 68: 18.8 ml/min/kg) were more similar t
- Page 69 and 70: Urinary excretion at 72 h post admi
- Page 71 and 72: into a physiologically based pharma
- Page 73 and 74: 327 Cytochrome P450 Gene Transcript
- Page 75 and 76:
(LD50 = 25 μM). Both pre- and post
- Page 77 and 78:
345 Prediction of Human Equivalent
- Page 79 and 80:
only remnants, including utriculi a
- Page 81 and 82:
363 MicroRNA Microarray Analysis of
- Page 83 and 84:
371 Mechanisms of Vesicating Agent
- Page 85 and 86:
381 Effect of Asbestos Exposure on
- Page 87 and 88:
PCB126 at doses of 0.1; 1 or 10μg/
- Page 89 and 90:
399 Immunotoxicity of the Nasal Ass
- Page 91 and 92:
407 The Dermal Exposure to Silica N
- Page 93 and 94:
416 Exposure to Triclosan Augments
- Page 95 and 96:
ventilation. Two independent method
- Page 97 and 98:
the German Federal Ministry of Educ
- Page 99 and 100:
443 Sonolytic Degradation of Pluron
- Page 101 and 102:
mice were anesthetized and lungs an
- Page 103 and 104:
mulations propelled the development
- Page 105 and 106:
fluorophore was removed by ultrafil
- Page 107 and 108:
The objective of this study was: (1
- Page 109 and 110:
489 Preliminary Toxicokinetics of N
- Page 111 and 112:
were twice as much susceptible to d
- Page 113 and 114:
improve the fit to the available in
- Page 115 and 116:
lead to i) a significant reduction
- Page 117 and 118:
(CYP1A1). Induction of this enzyme
- Page 119 and 120:
We have described a role for miRNAs
- Page 121 and 122:
individual treatment. Both compound
- Page 123 and 124:
554 Toxicogenomic Analysis of Envir
- Page 125 and 126:
563 Global Gene Expression Changes
- Page 127 and 128:
572 Preliminary Steps in a Whole Mi
- Page 129 and 130:
581 Chemical Characterization of Co
- Page 131 and 132:
fungicides. Studies indicated that
- Page 133 and 134:
of the used soil. Mortality and som
- Page 135 and 136:
from repeated doses, and the utilit
- Page 137 and 138:
618 Use of a Physiologically-Based
- Page 139 and 140:
emained as such through 24 hours po
- Page 141 and 142:
number of hepatic neutrophils remai
- Page 143 and 144:
human PRL (150 ng/ml) or human PL (
- Page 145 and 146:
time and Nrf2 -dependent increase i
- Page 147 and 148:
664 Hepatic Flavin-Containing Monoo
- Page 149 and 150:
673 Hypoxia Perturbs PCB-Induced Ar
- Page 151 and 152:
factor tool predicted the activatio
- Page 153 and 154:
to 50 μM Cd for 4 or 8 hours. Glob
- Page 155 and 156:
701 Reprogramming of the HepG2 Geno
- Page 157 and 158:
a process that was tested using di(
- Page 159 and 160:
a. Integrated Mode-of-Action (MoA)
- Page 161 and 162:
MitoPark mice also showed a dramati
- Page 163 and 164:
738 Human Antibodies Can Cross Guin
- Page 165 and 166:
Based on an initial 2 day dose-resp
- Page 167 and 168:
non-invasive methodology to measure
- Page 169 and 170:
768 Air Quality Impacts of Natural
- Page 171 and 172:
pathology by disrupting the normal
- Page 173 and 174:
pathways. Through these activities
- Page 175 and 176:
Approval of the Medical Research Et
- Page 177 and 178:
ile duct hyperplasia and hepatocell
- Page 179 and 180:
degradation enzymes, matrix metallo
- Page 181 and 182:
825 Image-Derived Models of Subcell
- Page 183 and 184:
used a number of strategies to mani
- Page 185 and 186:
ange of the population. It is gener
- Page 187 and 188:
858 Flexible and Transparent Comput
- Page 189 and 190:
available tool that provides a foun
- Page 191 and 192:
876 Web-Based Benchmark Dose Modeli
- Page 193 and 194:
885 A Mechanistic Approach to Under
- Page 195 and 196:
observed pharmacokinetic difference
- Page 197 and 198:
Funding: EU-FP7 (ENFIRO; grant agre
- Page 199 and 200:
913 Protective Role of Carnosine Ag
- Page 201 and 202:
measurable neurobehavioral endpoint
- Page 203 and 204:
For the TLDA- derived PCR data, a m
- Page 205 and 206:
samples within each group, strongly
- Page 207 and 208:
950 Smoking-Induced microRNA Change
- Page 209 and 210:
IL-1α. This approach has been adva
- Page 211 and 212:
969 Collaborative Project in JCIA f
- Page 213 and 214:
977 Predicting Eye Irritation of Ag
- Page 215 and 216:
organophosphates, organochlorines,
- Page 217 and 218:
996 Does the Barker Hypothesis Appl
- Page 219 and 220:
1005 Effects of Di(2-Ethylhexyl)-Ph
- Page 221 and 222:
compared to single housing. In conc
- Page 223 and 224:
1023 Hyperactivity of Rat and Mouse
- Page 225 and 226:
1 and Rho kinase inhibitor (HA1077)
- Page 227 and 228:
and subcutaneous and/or dermal infl
- Page 229 and 230:
inding in the liver, which involves
- Page 231 and 232:
tion, glycolysis, and amino acid me
- Page 233 and 234:
was isolated from frozen samples, a
- Page 235 and 236:
1079 MicroRNA Regulation of Alcohol
- Page 237 and 238:
an inducer of hyperglycemia) to cha
- Page 239 and 240:
1097 Deletion of Hepatocyte Nuclear
- Page 241 and 242:
study, we validated this short-term
- Page 243 and 244:
ferentiation and glucose metabolism
- Page 245 and 246:
tients treated with desipramine, th
- Page 247 and 248:
from mesenteric and uterine vascula
- Page 249 and 250:
Akt2 function preservation. For mec
- Page 251 and 252:
1152 Serum and Hepatic Alkaline Pho
- Page 253 and 254:
fold) with a dissociation constant
- Page 255 and 256:
1171 Fin Whale Cells Are More Resis
- Page 257 and 258:
develop analytical means to measure
- Page 259 and 260:
and location of ROS, and 2) cell an
- Page 261 and 262:
25% of patients receiving Imatinib
- Page 263 and 264:
lesions originate from is not clear
- Page 265 and 266:
Our analysis detected and corrected
- Page 267 and 268:
and APC. Results: Etirinotecan pego
- Page 269 and 270:
to the amount of fecal contaminatio
- Page 271 and 272:
1243 A High-Throughput Analytical M
- Page 273 and 274:
1252 Using Doubly-Labeled Water Ene
- Page 275 and 276:
implying that BPA is toxic to human
- Page 277 and 278:
1271 The Aryl Hydrocarbon Receptor
- Page 279 and 280:
1280 Aryl Hydrocarbon Receptor (AhR
- Page 281 and 282:
genes, suggesting a role for AHRRa
- Page 283 and 284:
and cellular proliferation. Underst
- Page 285 and 286:
1307 Toxicological Evaluation of th
- Page 287 and 288:
in blood as confirmed by a componen
- Page 289 and 290:
activation of scavenger receptor B
- Page 291 and 292:
AgNPs in dilutions of an environmen
- Page 293 and 294:
after dosing for TEM analysis. Imag
- Page 295 and 296:
various cell-lines. However, the da
- Page 297 and 298:
and the presence of leukocytes and
- Page 299 and 300:
1374 PCB 95 and IFN-gamma Exert Opp
- Page 301 and 302:
on estrogens. It is not known how t
- Page 303 and 304:
cell number, was reduced at PND10,
- Page 305 and 306:
1402 Repeated Exposure to Paraquat
- Page 307 and 308:
weeks (3 injections/week). We recor
- Page 309 and 310:
1421 Differential Antagonism of Tet
- Page 311 and 312:
of the syringe suggesting loss due
- Page 313 and 314:
1439 Interleukin 17 Responses Induc
- Page 315 and 316:
strains were exposed in triplicate
- Page 317 and 318:
1458 An In Vitro Placental Model Us
- Page 319 and 320:
Phagotest® (Glycotope Biotechnolog
- Page 321 and 322:
1477 Use of An In Vitro Flow Cytome
- Page 323 and 324:
1487 Evaluation of Genotoxicity of
- Page 325 and 326:
commonly used in textile industry.
- Page 327 and 328:
under hamster S9-activated and non-
- Page 329 and 330:
neutrophilic to eosinophilic respon
- Page 331 and 332:
1524 The Palmitoylation of Meh1, a
- Page 333 and 334:
for Dark, Pb afforded 0.607 mg/kg f
- Page 335 and 336:
to 5.4 or 54.1 mg/m3, respectively)
- Page 337 and 338:
1552 Body-Residue Based Environment
- Page 339 and 340:
1561 Identifying No Observed Effect
- Page 341 and 342:
studies/endpoints led by academic i
- Page 343 and 344:
1580 In Vitro Episkin Skin Corrosio
- Page 345 and 346:
RXR, opening the possibility that t
- Page 347 and 348:
1601 Enhanced Susceptibility of Fat
- Page 349 and 350:
potential to impact the safety asse
- Page 351 and 352:
A dataset of over 200 compounds cov
- Page 353 and 354:
that link in vivo outcomes (includi
- Page 355 and 356:
in humans, occurring in eight newbo
- Page 357 and 358:
novel mechanisms of action where th
- Page 359 and 360:
their homes, learn about historic a
- Page 361 and 362:
toxicology where Tox-21c could have
- Page 363 and 364:
compounds and Colcemide as an aneug
- Page 365 and 366:
dose dependent increases (p< 0.05)
- Page 367 and 368:
1707 Dose Response and Temporality
- Page 369 and 370:
several cells, including cancer cel
- Page 371 and 372:
1727 Characterization of Cigarette
- Page 373 and 374:
1736 Coating Nanoporous Alumina: Ce
- Page 375 and 376:
1745 Comparison of Toxicity of Bare
- Page 377 and 378:
using microscopy, cytotoxicity test
- Page 379 and 380:
ona, and 1.8 folds lower than the d
- Page 381 and 382:
RESULTS: Electronic microscopy stud
- Page 383 and 384:
effect of its flavonolignans. Becau
- Page 385 and 386:
These results suggest that mollugin
- Page 387 and 388:
m266.2 were not different from thos
- Page 389 and 390:
and associated drug accumulation, w
- Page 391 and 392:
1820 Application of Canine Kidney T
- Page 393 and 394:
1829 Effect of Body-Weight Loading
- Page 395 and 396:
mechanisms of cell death, we invest
- Page 397 and 398:
post-translational modifications of
- Page 399 and 400:
as oxidative stress, Ca2+ dysregula
- Page 401 and 402:
studies assessing cognitive and mot
- Page 403 and 404:
spine density of hippocampal pyrami
- Page 405 and 406:
individually or in combinations, in
- Page 407 and 408:
1893 A Comparative Study on Renal T
- Page 409 and 410:
same hand and between washed and no
- Page 411 and 412:
1911 Molecular, Cellular, and Histo
- Page 413 and 414:
1920 Endocrine Modulatory Effects o
- Page 415 and 416:
CYP19 mRNA levels were observed wit
- Page 417 and 418:
males and females. In efforts to bl
- Page 419 and 420:
worker’s capacity to adapt to hea
- Page 421 and 422:
from different studies indicates th
- Page 423 and 424:
1966 Associations between Carcinoge
- Page 425 and 426:
1975 Assessment of the Impacts of C
- Page 427 and 428:
For this analysis, nine PCBs with d
- Page 429 and 430:
1993 PBDE-100 Induces Mitochondrial
- Page 431 and 432:
2002 Cyp1b1-Deficiency Alters Struc
- Page 433 and 434:
enzymes and xenobiotic transporters
- Page 435 and 436:
protected against p-aminophenol (PA
- Page 437 and 438:
status has shown much promise. Howe
- Page 439 and 440:
esidues in proteins. The significan
- Page 441 and 442:
where no peak (same action througho
- Page 443 and 444:
were exposed to ethyl-alcohol via t
- Page 445 and 446:
2066 Validation of a 7-Color Flow C
- Page 447 and 448:
tive and detoxification genes. In a
- Page 449 and 450:
activated B cells and BCL-6, a tran
- Page 451 and 452:
later time points. Therefore, BPA e
- Page 453 and 454:
2102 Brominated Diphenyl Ether-47 I
- Page 455 and 456:
distribution and excretion or other
- Page 457 and 458:
serum Inhibin B was never changed.
- Page 459 and 460:
2130 Structural Changes in Various
- Page 461 and 462:
Methods: Adult male Fisher 344 rats
- Page 463 and 464:
asked what genes are involved in Me
- Page 465 and 466:
study examined whether combined Pb+
- Page 467 and 468:
elated to dried blood spots and mas
- Page 469 and 470:
15(R) D2 increased by 3.3 / 2.3-fol
- Page 471 and 472:
otic transcription factors nuclear
- Page 473 and 474:
genes. On the other hand, the creat
- Page 475 and 476:
2203 Resistance to Dioxin-Induced H
- Page 477 and 478:
data because the human data were no
- Page 479 and 480:
odent cancer bioassay of MTBE in dr
- Page 481 and 482:
(BMCL) estimates were extrapolated
- Page 483 and 484:
outcomes which differ from those ou
- Page 485 and 486:
2250 Validation of the Yeast Estrog
- Page 487 and 488:
in cell index, indicative of cytoto
- Page 489 and 490:
platform maybe most appropriate for
- Page 491 and 492:
200, 1000, or 2000 parts per billio
- Page 493 and 494:
2288 Paradoxical Effects of Ongoing
- Page 495 and 496:
for intracellular tracking of GR us
- Page 497 and 498:
2306 Evaluating Arsenic Speciation
- Page 499 and 500:
2316 Integrative Toxicopathological
- Page 501 and 502:
improve food safety is to reduce ex
- Page 503 and 504:
ased on human oral challenge studie
- Page 505 and 506:
2344 The Global Burden of Disease C
- Page 507 and 508:
HDACs had opposite effects, suggest
- Page 509 and 510:
useful in human health risk assessm
- Page 511 and 512:
1.7% in mucosal side. These results
- Page 513 and 514:
2381 Silica Nanoparticles Induce Ac
- Page 515 and 516:
have been well-demonstrated to be o
- Page 517 and 518:
2400 Fibrinogen: A New Kid on the B
- Page 519 and 520:
all critical factors. Vital organ s
- Page 521 and 522:
identifying QSARs that are applicab
- Page 523 and 524:
after the training, and the percent
- Page 525 and 526:
sham control group was included to
- Page 527 and 528:
after 15 min incubation with the C8
- Page 529 and 530:
2462 Nonhuman Primate Sexual Maturi
- Page 531 and 532:
2472 Modeling Human Genetic Variabi
- Page 533 and 534:
two subgroups, hippocampus were dis
- Page 535 and 536:
2495 Physiologically-Based Pharmaco
- Page 537 and 538:
plexes with important functional gr
- Page 539 and 540:
Notes SOT 2013 AnnuAl MeeTing 535
- Page 541 and 542:
Author Index (Continued) B Baan, R
- Page 543 and 544:
Author Index (Continued) Cassis, L
- Page 545 and 546:
Author Index (Continued) Dodmane, P
- Page 547 and 548:
Author Index (Continued) Gilpin, S
- Page 549 and 550:
Author Index (Continued) Huh, G 18
- Page 551 and 552:
Author Index (Continued) Krantz, Q
- Page 553 and 554:
Author Index (Continued) Martin, S
- Page 555 and 556:
Author Index (Continued) Niklas, J
- Page 557 and 558:
Author Index (Continued) Rana, P 2
- Page 559 and 560:
Author Index (Continued) Shin, K 6
- Page 561 and 562:
Author Index (Continued) Touissant,
- Page 563 and 564:
Author Index (Continued) Wormser, U
- Page 565 and 566:
Abstract Keyword Index (Continued)
- Page 567 and 568:
Abstract Keyword Index (Continued)
- Page 569 and 570:
Abstract Keyword Index (Continued)
- Page 571 and 572:
Abstract Keyword Index (Continued)
- Page 573 and 574:
Abstract Keyword Index (Continued)
- Page 575 and 576:
Abstract Keyword Index (Continued)
- Page 577 and 578:
Abstract Keyword Index (Continued)
- Page 579 and 580:
e O cial Journal of the Society of